🚀 VC round data is live in beta, check it out!
HLB Life Science Valuation Multiples
Discover revenue and EBITDA valuation multiples for HLB Life Science and similar public comparables like Amplitude Energy, Genie Energy, TotalEnergies Marketing Ghana, SAMIR and more.
HLB Life Science Overview
About HLB Life Science
HLB Life Science Co Ltd and its subsidiaries are engaged in the medicare business, bio development business, medical device business, and drug distribution business. The company is a medical device for in vitro diagnostics.The main business is the Medicare business, which includes foot and manufacturing, quasi-drug component development, and finished product consignment production.
Founded
1998
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$470M
HLB Life Science Financials
HLB Life Science reported last fiscal year revenue of $31M and negative EBITDA of ($57M).
In the same fiscal year, HLB Life Science generated ($337K) in gross profit, ($57M) in EBITDA losses, and had net loss of ($68M).
HLB Life Science P&L
In the most recent fiscal year, HLB Life Science reported revenue of $31M and EBITDA of ($57M).
HLB Life Science expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $31M | XXX | XXX | XXX |
| Gross Profit | — | XXX | ($337K) | XXX | XXX | XXX |
| Gross Margin | — | XXX | (1%) | XXX | XXX | XXX |
| EBITDA | — | XXX | ($57M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (183%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (46%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($68M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (218%) | XXX | XXX | XXX |
| Net Debt | — | — | $98M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
HLB Life Science Stock Performance
HLB Life Science has current market cap of $371M, and enterprise value of $470M.
Market Cap Evolution
HLB Life Science's stock price is $3.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $470M | $371M | 0.0% | XXX | XXX | XXX | $-0.56 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHLB Life Science Valuation Multiples
HLB Life Science trades at 15.1x EV/Revenue multiple, and (8.2x) EV/EBITDA.
HLB Life Science Financial Valuation Multiples
As of April 19, 2026, HLB Life Science has market cap of $371M and EV of $470M.
Equity research analysts estimate HLB Life Science's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
HLB Life Science has a P/E ratio of (5.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $371M | XXX | $371M | XXX | XXX | XXX |
| EV (current) | $470M | XXX | $470M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 15.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (8.2x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (32.8x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | (1394.0x) | XXX | XXX | XXX |
| P/E | — | XXX | (5.5x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (14.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified HLB Life Science Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
HLB Life Science Margins & Growth Rates
HLB Life Science's revenue in the last fiscal year declined by (55%).
HLB Life Science Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (55%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (183%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (423%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 7% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 45% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
HLB Life Science Public Comps
See public comps and valuation multiples for other Energy Production comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| HLB Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Amplitude Energy | XXX | XXX | XXX | XXX | XXX | XXX |
| Genie Energy | XXX | XXX | XXX | XXX | XXX | XXX |
| TotalEnergies Marketing Ghana | XXX | XXX | XXX | XXX | XXX | XXX |
| SAMIR | XXX | XXX | XXX | XXX | XXX | XXX |
| Okea | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
HLB Life Science M&A Activity
HLB Life Science acquired XXX companies to date.
Last acquisition by HLB Life Science was on XXXXXXXX, XXXXX. HLB Life Science acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by HLB Life Science
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialHLB Life Science Investment Activity
HLB Life Science invested in XXX companies to date.
HLB Life Science made its latest investment on XXXXXXXX, XXXXX. HLB Life Science invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by HLB Life Science
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout HLB Life Science
| When was HLB Life Science founded? | HLB Life Science was founded in 1998. |
| Where is HLB Life Science headquartered? | HLB Life Science is headquartered in South Korea. |
| Who is the CEO of HLB Life Science? | HLB Life Science's CEO is Sang-woo Nam. |
| Is HLB Life Science publicly listed? | Yes, HLB Life Science is a public company listed on Korea Exchange. |
| What is the stock symbol of HLB Life Science? | HLB Life Science trades under 067630 ticker. |
| When did HLB Life Science go public? | HLB Life Science went public in 2008. |
| Who are competitors of HLB Life Science? | HLB Life Science main competitors are Amplitude Energy, Genie Energy, TotalEnergies Marketing Ghana, SAMIR. |
| What is the current market cap of HLB Life Science? | HLB Life Science's current market cap is $371M. |
| What is the current revenue of HLB Life Science? | HLB Life Science's last fiscal year revenue is $31M. |
| What is the current EV/Revenue multiple of HLB Life Science? | Current revenue multiple of HLB Life Science is 15.1x. |
| Is HLB Life Science profitable? | No, HLB Life Science is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.